Bank of America’s Albany Molecular Research Inc AMRI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-37,238
| Closed | -$808K | – | 7494 |
|
|
2017
Q2 | $808K | Sell |
37,238
-37,052
| -50% | -$672K | ﹤0.01% | 4573 |
|
|
2017
Q1 | $1.04M | Buy |
74,290
+54,025
| +267% | +$885K | ﹤0.01% | 4396 |
|
|
2016
Q4 | $380K | Buy |
20,265
+18,428
| +1,003% | +$313K | ﹤0.01% | 4991 |
|
|
2016
Q3 | $30K | Sell |
1,837
-1,477
| -45% | -$21.9K | ﹤0.01% | 5968 |
|
|
2016
Q2 | $44K | Buy |
3,314
+2,582
| +353% | +$37.7K | ﹤0.01% | 5884 |
|
|
2016
Q1 | $11K | Sell |
732
-22,764
| -97% | -$357K | ﹤0.01% | 6377 |
|
|
2015
Q4 | $467K | Buy |
23,496
+6,769
| +40% | +$129K | ﹤0.01% | 4864 |
|
|
2015
Q3 | $292K | Sell |
16,727
-19,155
| -53% | -$390K | ﹤0.01% | 5133 |
|
|
2015
Q2 | $726K | Buy |
35,882
+20,552
| +134% | +$397K | ﹤0.01% | 4386 |
|
|
2015
Q1 | $270K | Buy |
15,330
+8,784
| +134% | +$150K | ﹤0.01% | 4735 |
|
|
2014
Q4 | $107K | Buy |
6,546
+6,097
| +1,358% | +$112K | ﹤0.01% | 5838 |
|
|
2014
Q3 | $10K | Sell |
449
-1,460
| -76% | -$29.9K | ﹤0.01% | 7345 |
|
|
2014
Q2 | $38K | Sell |
1,909
-18,104
| -90% | -$307K | ﹤0.01% | 6849 |
|
|
2014
Q1 | $372K | Buy |
20,013
+4,954
| +33% | +$68.2K | ﹤0.01% | 4869 |
|
|
2013
Q4 | $152K | Buy |
15,059
+12,352
| +456% | +$149K | ﹤0.01% | 5819 |
|
|
2013
Q3 | $35K | Sell |
2,707
-53,363
| -95% | -$656K | ﹤0.01% | 6633 |
|
|
2013
Q2 | $666K | Buy |
+56,070
| New | +$607K | ﹤0.01% | 4467 |
|
Other funds holding AMRI
Bank of America's AMRI Position: Q3 2017 in Review
Bank of America sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 37,238 shares — an estimated $808K sold.
Bank of America first reported a position in AMRI in Q2 2013 and held it in 17 quarters. The position peaked at $1.04M in Q1 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.
- Bank of America reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
- Bank of America sold 37,238 Albany Molecular Research Inc shares in Q3 2017, an estimated $808K.
- Bank of America first reported a position in Albany Molecular Research Inc in Q2 2013 and held it in 17 quarters.
- Bank of America's Albany Molecular Research Inc position peaked at $1.04M in Q1 2017.
- 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.
Based on Bank of America's 13F filing for Q3 2017, filed 14 Nov 2017.